Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for amlodipine benzenesulfonate tablets
Announcement of Yiping Hong (300723.SZ): The company's wholly-owned subsidiary, Guangzhou Yiping Hong Pharmaceutical Co., Ltd., recently received a notification from the country...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Group Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the amlodipine besylate tablet. Indications for amlodipine besylate tablets include: hypertension and coronary artery disease (CAD).
Related Articles

EB SECURITIES: Hong Kong stocks may show a volatile trend, but the long-term allocation cost-effectiveness of assets such as new consumer and innovative drugs remains relatively high.

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.

New Stock News | Shandong Linglong Tyre (601966.SH) submits application to Hong Kong Stock Exchange, becoming China's largest OE tire manufacturer.
EB SECURITIES: Hong Kong stocks may show a volatile trend, but the long-term allocation cost-effectiveness of assets such as new consumer and innovative drugs remains relatively high.

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.

New Stock News | Shandong Linglong Tyre (601966.SH) submits application to Hong Kong Stock Exchange, becoming China's largest OE tire manufacturer.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025